You Are Invited to a One-time LIVE CME/CPE/CNE Webcast! The Managed Care Review Board® - Examining the Optimal Treatment, Care Management, and Benefit Designs for Major Depressive Disorder Live Webcast Date Thursday, May 25, 2017 from 12:00 PM - 2:00 PM ET

Jointly provided by     This activity is supported by an independent educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.

Check back in July, 2017 for an on-demand activity based on this webcast.

REVIEW BOARD TOPICS

Recommendations from the APA Practice Guidelines with plan algorithms Integrate methods to address the treatment gap created by low rates of remission for MDD patients Current comparative effectiveness research and pharmacoeconomic models Decision-support systems and practice related tools to improve access and outcomes

REVIEW BOARD FACULTY

Jeffrey Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx/MagellanRx Edmund Pezalla, MD, MPH CEO Enlightenment Bioconsult Fadia Tohme-Shaya, PhD, MPH Professor and Vice Chair for Academic Affairs University of Maryland School of Pharmacy Charles L. Raison, MD Associate Professor Department of Psychiatry College of Medicine Barry and Janet Lang Associate Professor John and Doris Norton School of Family and Consumer Sciences

WHO SHOULD ATTEND?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, pharmacy directors, specialty pharmacists, quality directors, care managers, registered nurses, and other managed care and payer organization professionals.

STATEMENT OF NEED / PROGRAM OVERVIEW

Major depressive disorder (MDD) is the second most common psychiatric disorder in the United States. It is a serious chronic medical illness that affects 6.7% of the United States (US) population each year. Women are 70% more likely than men to experience depression during their lifetime. Unlike normal emotional experiences of sadness, loss, or passing mood states, MDD is characterized by persistency: symptoms last for weeks or more, and significantly hinder daily functioning. There is no single cause of MDD; psychological, biological, genetic, and environmental factors contribute to its development. This activity will provide instruction on current and emerging treatment strategies, mental health benefit management, and patient care strategies for managed care professionals to use to improve overall health and economic outcomes for patients with MDD. The educational format of The Managed Care Review Board® will feature a multi-specialty, multi-professional faculty that collaborate, under the leadership of an Activity Chair, on the review of the clinical data, current guidelines, and economic data of a class of therapeutics. Similar to a mock pharmacy and therapeutics committee format, the program will include time for peer-to-peer discussion and debate among the diverse group of faculty members and the audience.

EDUCATIONAL OBJECTIVES

At the conclusion of this activity, participants should be able to demonstrate improved ability to: Integrate recommendations from the APA Practice Guidelines with plan algorithms to ensure appropriate treatment and access to care for patients with MDD Employ optimal therapeutic and benefit management approaches to address the treatment gap created by low rates of remission for MDD patients within insured and/or managed populations Utilize data from current comparative effectiveness research and pharmacoeconomic models to make informed decisions that ensure appropriate access to optimal MDD therapies Implement decision-support systems and practice related tools to improve access and outcomes for patients with MDD

AGENDA

Pre-Activity Learning Assessment and Opening Comments Jeffrey Dunn, PharmD, MBA Assessing the Clinical Benefits of Optimal MDD Treatments in a Managed Care Setting Charles L. Raison, MD Integration of APA Practice Guidelines with Managed Care Algorithms Edmund Pezalla, MD, MPH Analyzing the Available Data to Assess the Value of Treatment Options Fadia Tohme-Shaya, PhD, MPH Care Strategies and Plan Benefit Designs to Maximize the Value of Appropriate MDD Therapies Jeffrey Dunn, PharmD, MBA Audience Question and Answer Session Key Takeaways and Closing Comments Post-activity Assessment and Evaluation

ACCREDITATION INFORMATION

Physician Continuing Medical Education This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Pharmacy Education

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - 0809-9999-17-607-L01-P Type of Activity: Application For Pharmacists: After receipt of a completed activity evaluation form you will be provided with instructions to have your credit immediately uploaded to CPE Monitor. Continuing Nursing Education Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This educational activity for 2.0 contact hours is provided by Postgraduate Institute for Medicine. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you.

Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Hardware/Software Requirements Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up. Fee Information There is no fee for this educational activity. Policy on Privacy and Confidentiality Please see final activity for the policy on privacy and confidentiality that relates to this internet activity. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.